Payer PolicyActive
Mammary Ductoscopy, Aspiration and Lavage - (0057)
CIGNA-0057
Cigna
Effective: January 15, 2025
Updated: December 6, 2025
created · Dec 2, 2025
Policy Summary
Cigna considers mammary ductoscopy, ductal lavage, and non‑invasive mammary duct aspiration devices (e.g., HALO™, MASCT) experimental, investigational, or unproven for all indications and therefore not covered. Providers must bill with appropriate covered codes (use of CPT 19499 for these procedures is also considered experimental and claims without covered codes will be denied); professional guidelines (NCCN, NCI) do not recommend these procedures.
Coverage Criteria Preview
Key requirements from the full policy
"None — mammary ductoscopy (MD), ductal lavage of the mammary ducts, and mammary duct aspiration by a non-invasive collection device (e."
Sign up to see full coverage criteria, indications, and limitations.